TTD Drug ID: DNC008994

Drug Information
Name	WAY-252623
Indication	Not Available			Experimental
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
InChI	1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8 -5-12)16-2-1-3-17(19(16)28-29)21(25,26)27/h1-10H,11H2
InChIKey	KYWWJENKIMRJBI-UHFFFAOYSA-N
Canonical SMILES	C1=CC2=C(N(N=C2C(=C1)C(F)(F)F)CC3=C(C=C(C=C3)F)Cl)C4=CC=C(C=C4)F
Target	Androgen Receptor			Inhibitor	[1]
	Glucocorticoid receptor			Inhibitor	[1]
	LXR-alpha			Inhibitor	[1]
	LXR-beta			Inhibitor	[1]
	Pregnane X receptor			Inhibitor	[1]
Ref 1	J Med Chem. 2008 Nov 27;51(22):7161-8.Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.